CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Total Revenues	$ 11,723	$ 6,293	$ 557,369	$ 60,445
Costs and Expenses
Costs of revenue	687,885	5,528	1,184,528	101,156
Research, development and manufacturing operations	1,086,513	150,060	2,716,395	485,592
Selling, general and administrative	882,641	315,660	2,244,771	505,053
Depreciation and amortization	15,111	26,325	40,047	137,978
Total Costs and Expenses	2,672,150	497,573	6,185,741	1,229,779
Loss from Operations	(2,660,427)	(491,280)	(5,628,372)	(1,169,334)
Other Income/(Expense)
Other income/(expense), net	67,644	3,055,366	68,443	3,314,966
Interest expense	(167,983)	(963,648)	(899,533)	(3,227,112)
Change in fair value of derivatives and gain/(loss) on extinguishment of liabilities, net	195,852	990,183	4,047,993	8,707,333
Total Other Income/(Expense)	95,513	3,081,901	3,216,903	8,795,187
Net Income/(Loss)	$ (2,564,914)	$ 2,590,621	$ (2,411,469)	$ 7,625,853
Net Income/(Loss) Per Share (Basic)	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net Income/(Loss) Per Share (Diluted)	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Weighted Average Common Shares Outstanding (Basic)	19,074,521,203	5,230,490,450	18,531,805,287	5,053,300,857
Weighted Average Common Shares Outstanding (Diluted)	19,074,521,203	66,848,261,292	18,531,805,287	65,693,072,463
Products
Total Revenues	$ 11,723	$ 6,293	$ 557,369	$ 60,445